Integra LifeSciences Reports Third Quarter 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Wall St futures pause after AI rally, focus on Mideast tensions
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Lake Street Capital Markets Upgrades Integra LifeSciences (IART) to Buy
October 28, 2016 8:26 AM EDTLake Street Capital Markets upgraded Integra LifeSciences (NASDAQ: IART) from Hold to Buy with a price target of $92.00.
For an analyst ratings summary and ratings history on Integra LifeSciences click here. For more ratings news on Integra LifeSciences click here.
Shares of Integra LifeSciences closed at $77.07 yesterday.
... MoreIntegra LifeSciences (IART) Tops Q3 EPS by 4c
October 27, 2016 4:08 PM EDTIntegra LifeSciences (NASDAQ: IART) reported Q3 EPS of $0.93, $0.04 better than the analyst estimate of $0.89. Revenue for the quarter came in at $250.3 million versus the consensus estimate of $249.3 million.
GUIDANCE:
Integra LifeSciences sees FY2016 EPS of $3.47-$3.53, versus the consensus of... More
